In addition to regular, unmodified EVs, in-EV offers EVs bioengineered with proteins. Thanks to Ciloa’s pilot peptide (PP) technology, which actively sorts proteins with EVs, none of these exogenous proteins are fused with overexpressed regular EV proteins (such as tetraspanins).